Cargando…
What is a reasonable framework for new non-validated treatments?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935739/ https://www.ncbi.nlm.nih.gov/pubmed/33586046 http://dx.doi.org/10.1007/s11017-020-09537-6 |
| _version_ | 1783661063518027776 |
|---|---|
| author | Helgesson, Gert |
| author_facet | Helgesson, Gert |
| author_sort | Helgesson, Gert |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7935739 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Netherlands |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79357392021-03-19 What is a reasonable framework for new non-validated treatments? Helgesson, Gert Theor Med Bioeth Article Springer Netherlands 2021-02-14 2020 /pmc/articles/PMC7935739/ /pubmed/33586046 http://dx.doi.org/10.1007/s11017-020-09537-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Article Helgesson, Gert What is a reasonable framework for new non-validated treatments? |
| title | What is a reasonable framework for new non-validated treatments? |
| title_full | What is a reasonable framework for new non-validated treatments? |
| title_fullStr | What is a reasonable framework for new non-validated treatments? |
| title_full_unstemmed | What is a reasonable framework for new non-validated treatments? |
| title_short | What is a reasonable framework for new non-validated treatments? |
| title_sort | what is a reasonable framework for new non-validated treatments? |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935739/ https://www.ncbi.nlm.nih.gov/pubmed/33586046 http://dx.doi.org/10.1007/s11017-020-09537-6 |
| work_keys_str_mv | AT helgessongert whatisareasonableframeworkfornewnonvalidatedtreatments |